No Data
No Data
Express News | Twining Biotech: There have been no major changes in the company's daily business conditions or internal and external production and operation environment
The synthetic biology concept strengthened in the afternoon, with Channing Biotech, Shengda Biotech, Blue Bio, and Yiduoli rising and stopping, while Lukang Pharmaceutical, Hanyu Pharmaceutical, and Meihua Biotech followed suit.
The synthetic biology concept strengthened in the afternoon, with Channing Biotech, Shengda Biotech, Blue Bio, and Yiduoli rising and stopping, while Lukang Pharmaceutical, Hanyu Pharmaceutical, and Meihua Biotech followed suit.
The chemical pharmaceutical concept fluctuated and boosted the rise and fall of Twining Biotech
The chemical pharmaceutical concept fluctuated and picked up. Twining Biotech and Hypry both went up and down, while Alex, Tonghe Pharmaceuticals, Osecon, and Borui Pharmaceuticals followed suit.
Express News | The synthetic biology concept continues to be strong, and Twining Biotech surged 15%
Dongwu Securities released a research report on April 28 stating that it gave Channing Biotech (301301.SZ) a purchase rating. The main reasons for the rating include: 1) performance is accelerating quarterly, and I am optimistic that the company's profita
Dongwu Securities released a research report on April 28 stating that it gave Channing Biotech (301301.SZ) a purchase rating. The main reasons for the rating include: 1) performance is accelerating quarterly, and I am optimistic that the company's profitability will be restored; 2) the synthetic biology R&D pipeline is rich, production capacity is abundant, and the project is about to be implemented. (Mainichi Keizai Shimbun)
Twining Biotech (301301): Performance exceeds expectations, high demand for intermediates supports high performance growth
Key investment events: The company achieved revenue of 4.823 billion yuan in 2023 (+26.2%, same ratio in parentheses, same below); net profit attributable to mother of 941 million yuan (+128.6%); net profit not attributable to mother of 9.36 million yuan
No Data